应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
未开盘 12-23 16:08:09
8.880
+0.630
+7.64%
最高
8.880
最低
8.240
成交量
3.17亿
今开
8.300
昨收
8.250
日振幅
7.76%
总市值
1,023亿
流通市值
1,023亿
总股本
115.22亿
成交额
27.61亿
换手率
2.75%
流通股本
115.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
4.5亿!石药新公司来了
赛柏蓝 · 12-23 19:32
4.5亿!石药新公司来了
石药创新制药股份有限公司控股子公司达雷妥尤单抗注射液获临床试验批件
中金财经 · 12-23 16:55
石药创新制药股份有限公司控股子公司达雷妥尤单抗注射液获临床试验批件
12月,石药集团、百济神州、百花村医药等一批药企已“换帅”
制药网 · 12-23 15:17
12月,石药集团、百济神州、百花村医药等一批药企已“换帅”
港股期权 | 快手股价下挫,空头押注蜂拥加码;石药劲升6%,认购期权抢滩热涌
老虎资讯综合 · 12-23 12:50
港股期权 | 快手股价下挫,空头押注蜂拥加码;石药劲升6%,认购期权抢滩热涌
港股创新药概念股盘中拉升!石药集团涨超5%,荣昌生物涨超3%
老虎资讯综合 · 12-23 10:04
港股创新药概念股盘中拉升!石药集团涨超5%,荣昌生物涨超3%
石药集团(01093.HK)涨超4%
每日经济新闻 · 12-23 10:03
石药集团(01093.HK)涨超4%
智通港股沽空统计|12月23日
智通财经 · 12-23 08:20
智通港股沽空统计|12月23日
长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证
21世纪经济报道 · 12-23 08:10
长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证
智通港股股东权益披露|12月23日
智通财经 · 12-23 08:05
智通港股股东权益披露|12月23日
智通港股通资金流向统计(T+2)|12月23日
智通财经 · 12-23 07:31
智通港股通资金流向统计(T+2)|12月23日
主席兼执行董事蔡东晨增持石药集团(01093)1345.4万股 每股作价约8.2港元
智通财经 · 12-22 19:13
主席兼执行董事蔡东晨增持石药集团(01093)1345.4万股 每股作价约8.2港元
每日卖空追踪 | 石药集团 12月22日卖空量成交2556.2万股,卖空比例为14.81%
市场透视 · 12-22 16:30
每日卖空追踪 | 石药集团 12月22日卖空量成交2556.2万股,卖空比例为14.81%
石药新诺威董事CAI LEI(蔡磊)因工作变动辞任
中金财经 · 12-22 16:27
石药新诺威董事CAI LEI(蔡磊)因工作变动辞任
石药,1类减肥新药,获批临床!
药融CDMO之家 · 12-22 16:23
石药,1类减肥新药,获批临床!
国产新药:十亿美金 BD 大单爆了
丁香园 Insight 数据库 · 12-22 07:50
国产新药:十亿美金 BD 大单爆了
石药集团高层人事调整:“二代”蔡磊接棒CEO,与魏青杰共同出任副主席
财中社 · 12-21 16:19
石药集团高层人事调整:“二代”蔡磊接棒CEO,与魏青杰共同出任副主席
石药集团任命蔡为新任领导,正处于领导层过渡期CSPC Pharmaceutical Group Appoints Cai as New Head Amid Leadership Transition
动脉网 · 12-20
石药集团任命蔡为新任领导,正处于领导层过渡期CSPC Pharmaceutical Group Appoints Cai as New Head Amid Leadership Transition
石药集团CEO换人,蔡磊获委任为副主席及执行董事等职
CPHI制药在线 · 12-20
石药集团CEO换人,蔡磊获委任为副主席及执行董事等职
石药集团(01093):SYH2085片在中国获临床试验批准
智通财经 · 12-19
石药集团(01093):SYH2085片在中国获临床试验批准
石药集团(01093):魏青杰获委任为副主席、公司执行董事及首席运营官
智通财经 · 12-19
石药集团(01093):魏青杰获委任为副主席、公司执行董事及首席运营官
加载更多
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":8.88,"timestamp":1766477289002,"preClose":8.25,"halted":0,"volume":316765101,"delay":0,"floatShares":11522000000,"shares":11522000000,"eps":0.4086650550141172,"marketStatus":"未开盘","change":0.63,"latestTime":"12-23 16:08:09","open":8.3,"high":8.88,"low":8.24,"amount":2760823852,"amplitude":0.077576,"askPrice":8.88,"askSize":1568000,"bidPrice":8.86,"bidSize":52000,"shortable":3,"etf":0,"ttmEps":0.392624044428197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":8.25,"dividendRate":0.028371,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":2.119007332577369,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":false,"expireDate":1772035200000,"strike":"6.75","timestamp":1766460781689,"price":0.06,"volume":400,"amount":48000,"type":"*"},{"symbol":"CSP.HK","call":false,"expireDate":1769616000000,"strike":"7.00","timestamp":1766459713036,"price":0.04,"volume":250,"amount":20000,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4625,"impliedVolPercentile":0.3618},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2593497849","title":"4.5亿!石药新公司来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497849","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593497849?lang=zh_cn&edition=full","pubTime":"2025-12-23 19:32","pubTimestamp":1766489520,"startTime":"0","endTime":"0","summary":"本次投资资金全部来自两家公司自有资金,石药创新拟出资1.575亿元,占比35%;中奇制药拟出资2.925亿元,占比65%。对于从传统药企向创新药企转型的石药来说,新公司是其创新布局的重要一环。对外授权方面,石药2025年上半年收入达10.75亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-12-23/doc-inhcuyuh0592699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1226287792.SGD","IE00BZ08YT58.USD","LU1226287529.USD","LU1807302812.USD","SG9999004220.SGD","IE0008368742.USD","IE0008369823.USD","LU0501845795.SGD","LU1993786604.SGD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","HK0000165453.HKD","LU0315179316.USD","BK1521","LU1008478684.HKD","LU0314109678.HKD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU0072913022.USD","LU0326950275.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1328277881.USD","LU1813983027.USD","LU1152091168.USD","LU0880133367.SGD","BK1515","LU0140636845.USD","LU1226288170.HKD","LU1951186391.HKD","LU1226287875.USD","LU1226288253.USD","LU2039709279.SGD","LU1152091754.HKD","01093","IE00B543WZ88.USD","BK1191"],"gpt_icon":0},{"id":"2593432493","title":"石药创新制药股份有限公司控股子公司达雷妥尤单抗注射液获临床试验批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2593432493","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593432493?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:55","pubTimestamp":1766480123,"startTime":"0","endTime":"0","summary":"中访网数据 石药创新制药股份有限公司于近日发布公告,其控股子公司石药集团巨石生物制药有限公司研发的达雷妥尤单抗注射液,已获得国家药品监督管理局核准签发的《药物临床试验批准通知书》,受理号为CXSL2500876。公司表示将于近期启动临床试验。此次获得临床试验批准是该药物研发进程中的关键一步,但后续仍需完成临床试验并经国家药监局批准后方可上市销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251223/31884943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0314109678.HKD","BK1574","LU0140636845.USD","BK1515","LU1807302812.USD","LU1152091754.HKD","LU1226287792.SGD","LU1226288253.USD","IE00B031HY20.USD","LU1152091168.USD","IE0008369823.USD","LU1328277881.USD","LU1226288170.HKD","LU1226287875.USD","LU2039709279.SGD","LU1813983027.USD","IE0008368742.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","IE00B5MMRT66.SGD","BK1191","LU1960683339.HKD","LU1993786604.SGD","LU0315179316.USD","IE00BZ08YT58.USD","LU0326950275.SGD","IE00B543WZ88.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1951186391.HKD","HK0000165453.HKD","LU0067412154.USD","01477","LU0072913022.USD","BK1521","01093","LU1226287529.USD","LU0501845795.SGD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2593741940","title":"12月,石药集团、百济神州、百花村医药等一批药企已“换帅”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593741940","media":"制药网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593741940?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:17","pubTimestamp":1766474250,"startTime":"0","endTime":"0","summary":"如在近期,石药集团、百济神州、百花村医药等一批药企就已纷纷宣布“换帅”。12月19日,石药集团公告宣布执行董事蔡磊接任董事会副主席、首席执行官。12月12日,药明巨诺发布公告,宣布一系列核心管理层及董事会架构调整。除了上述企业,在12月以来,恒瑞医药、康恩贝、南新制药、振东制药等也已发布过高管变动公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223152053a46dc612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223152053a46dc612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","IE0008369823.USD","LU1951186391.HKD","LU0307460666.USD","IE00BZ08YS42.EUR","LU2543165471.USD","LU1023057109.AUD","IE00B5MMRT66.SGD","09939","LU0588546209.SGD","LU1008478684.HKD","LU1226287529.USD","LU1813983027.USD","LU1960683339.HKD","LU1152091168.USD","BK1161","IE00B543WZ88.USD","01093","LU0880133367.SGD","LU0315179316.USD","BK1191","LU0140636845.USD","LU0501845795.SGD","LU1719994722.HKD","LU2328871848.SGD","LU0326950275.SGD","IE00BZ08YR35.GBP","LU0359202008.SGD","LU1969619763.USD","HK0000165453.HKD","LU1226288170.HKD","BK1583","IE00BZ08YT58.USD","06160","LU1328277881.USD","01276","LU0067412154.USD","LU0314109678.HKD","LU0359201885.HKD","LU0072913022.USD","LU1152091754.HKD","LU1993786604.SGD","BK1500","LU1807302812.USD","LU2039709279.SGD","BK1515","SG9999004220.SGD","LU0359201612.USD","BK1588","IE00B031HY20.USD"],"gpt_icon":0},{"id":"1194426616","title":"港股期权 | 快手股价下挫,空头押注蜂拥加码;石药劲升6%,认购期权抢滩热涌","url":"https://stock-news.laohu8.com/highlight/detail?id=1194426616","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194426616?lang=zh_cn&edition=full","pubTime":"2025-12-23 12:50","pubTimestamp":1766465408,"startTime":"0","endTime":"0","summary":"$石药集团$涨超6%,期权方面:半日成交近1万张合约,其中于2026年1月29日到期行权价9.75港元的认购期权成交量居前,成交近700张合约。消息面上,香港联交所最新资料显示,12月22日,主席兼执行董事蔡东晨增持石药集团1345.4万股,每股作价8.1957港元,总金额约为1.1亿港元。增持后最新持股数目约为29.1亿股,最新持股比例为25.26%。近日,石药集团发布公告,集团开发的SYH2085片已获得中华人民共和国国家药品监督管理局批准,可在中国开展临床试验。","market":"hk","thumbnail":"https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01810","01093","00700","01024"],"gpt_icon":1},{"id":"1130488131","title":"港股创新药概念股盘中拉升!石药集团涨超5%,荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130488131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130488131?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:04","pubTimestamp":1766455472,"startTime":"0","endTime":"0","summary":"12月23日,港股创新药概念股盘中拉升,$石药集团(01093)$涨超5%,$恒瑞医药(01276)$、$三生制药(01530)$涨近3%,$先声药业(02096)$、$歌礼制药-B(01672)$、$康诺亚-B(02162)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","01672","01276","02096","01093","01477","01530","06978"],"gpt_icon":0},{"id":"2593012457","title":"石药集团(01093.HK)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593012457","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593012457?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:03","pubTimestamp":1766455409,"startTime":"0","endTime":"0","summary":"每经AI快讯,石药集团(01093.HK)涨超4%,截至发稿涨4.12%,报8.59港元,成交额4.43亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599251421.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599251421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1960683339.HKD","IE0008368742.USD","LU2039709279.SGD","LU1813983027.USD","LU1152091754.HKD","LU1226288253.USD","IE00BZ08YT58.USD","BK1515","LU0315179316.USD","IE00B543WZ88.USD","LU1993786604.SGD","IE0008369823.USD","LU0067412154.USD","SG9999004220.SGD","HK0000165453.HKD","LU0501845795.SGD","LU1328277881.USD","LU1152091168.USD","LU1226288170.HKD","LU1807302812.USD","IE00BZ08YS42.EUR","LU1226287875.USD","BK1521","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0326950275.SGD","LU0880133367.SGD","IE00B031HY20.USD","LU1008478684.HKD","BK1191","IE00BZ08YR35.GBP","LU1226287792.SGD","01093","LU0314109678.HKD","LU0072913022.USD","LU1226287529.USD","LU0140636845.USD"],"gpt_icon":0},{"id":"2593545139","title":"智通港股沽空统计|12月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593545139","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593545139?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:20","pubTimestamp":1766449228,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,华润啤酒-R、美团-WR、中国海洋石油-R上一交易日沽空比率位于前三位,分别为100.00%、93.03%、85.70%。阿里巴巴-SW、腾讯控股、小米集团-W的沽空金额位居前三,分别为12.93 亿元、12.42 亿元、10.84 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["80175","HTCD.SI","01908","BABA","HMTD.SI","LU0345776255.USD","LU0540923850.HKD","09988","80883","02899","LU0553294199.USD","IE0003851619.USD","01044","MIUmain","81810","XIACY","LU0061477393.USD","01093","00035","89618","HXXD.SI","IE00B031J352.USD","03690","80992","00700","03143","03968","LU0828237940.HKD","80291","00934","BK1166","01299","02343","LU0762542818.HKD","01810","80020","83690","81299","TCHmain","LU1366334578.USD","81211","ALBmain","LU0203345920.USD","METmain","00604","AAGIY","LU0499858602.USD","MPNGY"],"gpt_icon":1},{"id":"2593645198","title":"长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645198","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593645198?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:10","pubTimestamp":1766448612,"startTime":"0","endTime":"0","summary":"政策动向国家医保局:“十五五”时期长期护理保险制度将从试点转向全面建制12月22日,在2025全国长期护理保险高质量发展大会上,国家医保局党组书记、局长章轲在致辞时表示,经过试点,长期护理保险制度覆盖近3亿人,累计惠及超330万失能群众,基金支出超千亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233598873113.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233598873113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1152091168.USD","BK4090","603439","688580","SG9999004220.SGD","LU1008478684.HKD","LU2039709279.SGD","002086","BK0213","BK1521","LU0315179316.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","LU0501845795.SGD","BK0239","BK1191","PCT","IE00B031HY20.USD","LU1813983027.USD","LU0326950275.SGD","LU1226288170.HKD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1993786604.SGD","LU1960683339.HKD","LU0072913022.USD","BK0251","HK0000165453.HKD","LU0314109678.HKD","BK1515","IE0008369823.USD","LU1951186391.HKD","002873","LU1152091754.HKD","LU1226287792.SGD","BK0046","LU1807302812.USD","IE0008368742.USD","LU1226288253.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1328277881.USD","IE00B543WZ88.USD","LU1226287875.USD","BK0092","LU1226287529.USD"],"gpt_icon":0},{"id":"2593645914","title":"智通港股股东权益披露|12月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645914","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593645914?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:05","pubTimestamp":1766448301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,声通科技、石药集团、汇德收购-Z于2025年12月23日进行了最新股东权益披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","LU2039709279.SGD","LU0880133367.SGD","IE00BZ08YT58.USD","IE00B031HY20.USD","HK0000165453.HKD","LU0067412154.USD","LU0501845795.SGD","LU1226287875.USD","LU1807302812.USD","SG9999004220.SGD","IE0008368742.USD","IE0008369823.USD","LU1226287529.USD","LU1226288253.USD","LU1226288170.HKD","LU1152091754.HKD","LU1813983027.USD","IE00BZ08YS42.EUR","LU0314109678.HKD","LU1993786604.SGD","BK1191","LU0072913022.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1152091168.USD","LU1960683339.HKD","01093","LU1328277881.USD","LU0315179316.USD","IE00B543WZ88.USD","LU1226287792.SGD","BK1521","LU0140636845.USD","LU1951186391.HKD","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2593456295","title":"智通港股通资金流向统计(T+2)|12月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593456295","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593456295?lang=zh_cn&edition=full","pubTime":"2025-12-23 07:31","pubTimestamp":1766446262,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,12月18日,小米集团-W、美团-W、长飞光纤光缆南向资金净流入金额位列市场前三,分别净流入9.04 亿、4.76 亿、3.56 亿盈富基金、中国移动、信达生物南向资金净流出金额位列市场前三,分别净流出-14.20 亿、-12.95 亿、-2.71 亿在净流入比方面,南方恒指ETF、工银南方中国、美的置业以84.61%、75.00%、65.00%位列市场前三。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00386","03868","00857","89988","01952","00272","01801","00388","01810","HKXCY","02899","03037","02318","00006","03145","ALBmain","02328","03968","09985","82318","00107","03167","09899","HEXmain","01186","00016","01117","00003","01288","03690","06098","03328","00363","HMTD.SI","03121","00941","01093","06869","06160","01258","01686","PAImain","PNGAY","81810","03990","03442","03143","02800"],"gpt_icon":1},{"id":"2593215481","title":"主席兼执行董事蔡东晨增持石药集团(01093)1345.4万股 每股作价约8.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593215481","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593215481?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:13","pubTimestamp":1766402003,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,12月22日,主席兼执行董事蔡东晨增持石药集团(01093)1345.4万股,每股作价8.1957港元,总金额约为1.1亿港元。增持后最新持股数目约为29.1亿股,最新持股比例为25.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"主席兼执行董事蔡东晨增持石药集团(01093)1345.4万股 每股作价约8.2港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288253.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","LU0072913022.USD","LU0315179316.USD","LU1226287875.USD","BK1191","IE00B031HY20.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1152091168.USD","LU2039709279.SGD","LU0140636845.USD","LU1226288170.HKD","LU1226287529.USD","BK1521","LU1226287792.SGD","IE0008368742.USD","LU1951186391.HKD","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU1152091754.HKD","LU1807302812.USD","IE0008369823.USD","BK1515","IE00BZ08YR35.GBP","01093","LU1328277881.USD","LU1008478684.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1813983027.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"2593872994","title":"每日卖空追踪 | 石药集团 12月22日卖空量成交2556.2万股,卖空比例为14.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593872994","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593872994?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392218,"startTime":"0","endTime":"0","summary":"石药集团北京时间12月22日,涨0.61%,卖空量成交2556.2万股,较上一交易日减少57.94%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163235a46992e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163235a46992e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0880133367.SGD","IE00B031HY20.USD","LU1226287875.USD","LU1328277881.USD","IE0008369823.USD","LU0501845795.SGD","LU1008478684.HKD","LU1226288170.HKD","LU1226288253.USD","LU0315179316.USD","BK1515","IE0008368742.USD","LU1226287792.SGD","LU0140636845.USD","LU1813983027.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1960683339.HKD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1807302812.USD","LU1226287529.USD","BK1191","BK1521","IE00B543WZ88.USD","LU1993786604.SGD","LU1152091754.HKD","LU0072913022.USD","LU0314109678.HKD","IE00BZ08YS42.EUR","01093","SG9999004220.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU2039709279.SGD","LU0067412154.USD"],"gpt_icon":0},{"id":"2593100129","title":"石药新诺威董事CAI LEI(蔡磊)因工作变动辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2593100129","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593100129?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:27","pubTimestamp":1766392022,"startTime":"0","endTime":"0","summary":"中访网数据 石药创新制药股份有限公司于2025年12月22日发布公告,公司董事会收到董事CAI LEI(蔡磊)先生的书面辞职报告。CAI LEI(蔡磊)先生因工作变动原因,申请辞去公司董事职务,辞任后不再担任公司任何职务。其辞职报告自送达董事会之日起生效。公告显示,CAI LEI(蔡磊)先生原定任期至2026年4月6日届满,此次辞任未导致公司董事会成员低于法定最低人数,不会影响公司董事会的正常运作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251222/31881169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE00B543WZ88.USD","LU1226287792.SGD","LU2039709279.SGD","BK0226","BK1191","LU1226288253.USD","IE0008369823.USD","LU0315179316.USD","CAI","BK4139","IE0008368742.USD","LU0072913022.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1152091168.USD","300765","IE00B5MMRT66.SGD","LU1993786604.SGD","LU1152091754.HKD","BK4104","LU0140636845.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU1328277881.USD","LU1226287529.USD","BK1521","LU1807302812.USD","HK0000165453.HKD","SG9999004220.SGD","LU0067412154.USD","LU1960683339.HKD","LU0326950275.SGD","LU0314109678.HKD","LU1226288170.HKD","BK1515","IE00BZ08YS42.EUR","LU0501845795.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1951186391.HKD","01093","LU1813983027.USD"],"gpt_icon":0},{"id":"2593487244","title":"石药,1类减肥新药,获批临床!","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487244","media":"药融CDMO之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593487244?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:23","pubTimestamp":1766391799,"startTime":"0","endTime":"0","summary":"2025 年 11 月,JMT206 已率先获得 NMPA 批准临床试验,适应症为肥胖或超重合并至少一种体重相关合并症人群的体重管理。2025年以来,截至12月初,石药集团共有15款1类新药首次获批临床,包括 8 款化药和7款生物制品。今年 4 月,该药也已获 FDA 批准开展临床试验。2 款肥胖新药首次获批 IND今年 3 月,石药集团百克生物递交的 SYH2067 胶囊获批临床,适应症为用于减少热量饮食和增加体力活动的基础上对成人超重或肥胖患者的体重管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163716a6c09eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163716a6c09eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0326950275.SGD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1951186391.HKD","LU1813983027.USD","LU1226287875.USD","LU1226288170.HKD","SG9999004220.SGD","LU1152091754.HKD","IE00B543WZ88.USD","LU0140636845.USD","HK0000165453.HKD","LU0314109678.HKD","LU0880133367.SGD","BK1191","IE00B031HY20.USD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287529.USD","IE0008369823.USD","LU0315179316.USD","LU1152091168.USD","LU0072913022.USD","LU1960683339.HKD","BK1515","LU0501845795.SGD","01093","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1521","LU2039709279.SGD","LU1226287792.SGD","LU0067412154.USD","LU1328277881.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2593170975","title":"国产新药:十亿美金 BD 大单爆了","url":"https://stock-news.laohu8.com/highlight/detail?id=2593170975","media":"丁香园 Insight 数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593170975?lang=zh_cn&edition=full","pubTime":"2025-12-22 07:50","pubTimestamp":1766361045,"startTime":"0","endTime":"0","summary":"Insight 数据库显示,国内十亿美金级别的交易中,跨国药企作为买方的占比接近五成,贡献了超过一半的交易额。其中,罗氏对中国创新药资产最为青睐,年内共达成了 3 笔大额交易。另外,从单笔金额来看,国内与 MNC 达成的交易有 5 笔超过了 50 亿美元,其中涉及的产品有COPD 新药、心血管 siRNA 疗法、PD1 双抗、ADC 等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222075317a6bec512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222075317a6bec512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1583","LU2242644610.SGD","LU2328871848.SGD","LU0455707207.USD","01093","LU2097828474.EUR","LU0502904849.HKD","LU2097828805.USD","01530","HK0000165453.HKD","LU1969619763.USD","LU2097828557.USD","LU2097828631.EUR","LU2488822045.USD","LU2097828714.EUR","01801","BK1161"],"gpt_icon":0},{"id":"2593129901","title":"石药集团高层人事调整:“二代”蔡磊接棒CEO,与魏青杰共同出任副主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2593129901","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593129901?lang=zh_cn&edition=full","pubTime":"2025-12-21 16:19","pubTimestamp":1766305154,"startTime":"0","endTime":"0","summary":"石药集团(01093)发布公告,自2025年12月19日起,董事会进行了高层人事调整。张翠龙因工作调动不再担任副主席、首席执行官及授权代表,但仍将继续担任执行董事。蔡磊获委任为副主席、执行董事、首席执行官及授权代表,魏青杰获委任为副主席、执行董事及首席运营官。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512213597583055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1226288253.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","LU0072913022.USD","LU0315179316.USD","LU1226287875.USD","BK1191","IE00B031HY20.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1152091168.USD","LU2039709279.SGD","LU0140636845.USD","LU1226288170.HKD","LU1226287529.USD","BK1521","LU1226287792.SGD","IE0008368742.USD","LU1951186391.HKD","IE00B543WZ88.USD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU1152091754.HKD","LU1807302812.USD","IE0008369823.USD","BK1515","IE00BZ08YR35.GBP","01093","LU1328277881.USD","LU1008478684.HKD","LU0880133367.SGD","LU0326950275.SGD","LU1813983027.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"2592101071","title":"石药集团任命蔡为新任领导,正处于领导层过渡期CSPC Pharmaceutical Group Appoints Cai as New Head Amid Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2592101071","media":"动脉网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592101071?lang=zh_cn&edition=full","pubTime":"2025-12-20 15:33","pubTimestamp":1766215980,"startTime":"0","endTime":"0","summary":"by GOAI由GOAI生成Share To分享到CSPC Pharmaceutical Group has announced leadership changes, with Cai taking over as head of the company, succeeding Zhang. The transition marks a significant shift in the organization’s management structure. CSPC, a major player in the pharmaceutical industry, has not disclosed further details regarding the reasons behind this change or any strategic implications tied to the leadership transition..石药集团宣布了领导层的变动,蔡接替张成为公司的负责人。In addition to CSPC’s announcement, several other updates have emerged across the biotech and pharmaceutical sectors. ProFound and Nona have hired leaders specializing in artificial intelligence as part of their efforts to integrate AI into their operations. PureTech Health, BeOne, Breyer Capital, and NanOlogy LLC have also reported developments within their organizations.除了石药集团的公告外,生物技术和制药行业还出现了几项其他更新。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153620a462e76b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153620a462e76b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288170.HKD","IE0008369823.USD","LU1960683339.HKD","LU0315179316.USD","IE00BZ08YR35.GBP","LU1226288253.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287875.USD","HK0000165453.HKD","LU0326950275.SGD","LU1807302812.USD","LU0140636845.USD","LU1226287792.SGD","LU1328277881.USD","LU1993786604.SGD","BK1515","SG9999004220.SGD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1008478684.HKD","LU0314109678.HKD","LU0067412154.USD","LU2039709279.SGD","LU1813983027.USD","LU0880133367.SGD","LU1951186391.HKD","IE00B031HY20.USD","LU1152091168.USD","BK1191","BK1521","IE00B5MMRT66.SGD","LU1226287529.USD","IE0008368742.USD","01093"],"gpt_icon":0},{"id":"2592110481","title":"石药集团CEO换人,蔡磊获委任为副主席及执行董事等职","url":"https://stock-news.laohu8.com/highlight/detail?id=2592110481","media":"CPHI制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592110481?lang=zh_cn&edition=full","pubTime":"2025-12-20 15:30","pubTimestamp":1766215851,"startTime":"0","endTime":"0","summary":"公告显示,为石药集团服务多年的“老将”张翠龙因工作调动,卸任董事会副主席、首席执行官及授权代表职务,但仍将留任执行董事。此次卸任的CEO张翠龙自1996年加入石药集团,并于2018年获委任为执行董事;2019年担任副主席、轮值行政总裁;2022年委任为行政总裁,一路见证了石药集团的重要发展阶段。新任CEO蔡磊则是石药集团董事会主席、执行董事及主要股东蔡东晨之子,也是执行董事蔡鑫的胞兄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220153406a462e64c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091754.HKD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1226287792.SGD","LU1226287875.USD","BK1515","SG9999004220.SGD","LU1960683339.HKD","LU1226288253.USD","LU1008478684.HKD","LU0067412154.USD","LU0315179316.USD","IE00B543WZ88.USD","LU2039709279.SGD","LU1807302812.USD","LU0326950275.SGD","01093","IE0008369823.USD","IE0008368742.USD","LU0140636845.USD","IE00BZ08YS42.EUR","LU0072913022.USD","BK1521","LU1951186391.HKD","LU1226288170.HKD","LU1226287529.USD","LU1328277881.USD","LU0501845795.SGD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0880133367.SGD","BK1191","LU1813983027.USD","HK0000165453.HKD","IE00B031HY20.USD","LU1152091168.USD"],"gpt_icon":0},{"id":"2592162178","title":"石药集团(01093):SYH2085片在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162178","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592162178?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:17","pubTimestamp":1766150269,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的SYH2085片已获得中华人民共和国国家药品监督管理局批准,可在中国开展临床试验。本次获批的临床适应症为用于治疗成人及12岁以上青少年单纯性甲型和乙型流感。该产品有望成为治疗流感的有效药物,具有较高的临床开发价值,并将进一步丰富集团在抗感染治疗领域的产品管线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0315179316.USD","LU0314109678.HKD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1328277881.USD","HK0000165453.HKD","LU2039709279.SGD","LU1152091168.USD","BK1521","LU0326950275.SGD","LU1226287792.SGD","IE0008368742.USD","LU1226288253.USD","LU1226287875.USD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1226287529.USD","BK1515","LU0072913022.USD","LU0880133367.SGD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1152091754.HKD","IE00B031HY20.USD","LU1226288170.HKD","LU1813983027.USD","SG9999004220.SGD","IE00BZ08YT58.USD","IE00B543WZ88.USD","LU1807302812.USD","LU1960683339.HKD","LU0140636845.USD","BK1191","LU0067412154.USD","IE0008369823.USD","LU1951186391.HKD","01093"],"gpt_icon":0},{"id":"2592316211","title":"石药集团(01093):魏青杰获委任为副主席、公司执行董事及首席运营官","url":"https://stock-news.laohu8.com/highlight/detail?id=2592316211","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592316211?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:14","pubTimestamp":1766150083,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,自2025年12月19日起生效:张翠龙先生因工作调动而不再担任董事会副主席、公司首席执行官及根据香港联合交易所有限公司证券上市规则第3.05条项下公司授权代表,但将继续担任公司执行董事;蔡磊博士获委任为副主席、公司执行董事、首席执行官及授权代表;魏青杰先生获委任为副主席、公司执行董事及首席运营官。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"石药集团(01093):魏青杰获委任为副主席、公司执行董事及首席运营官","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","LU1807302812.USD","SG9999004220.SGD","IE0008369823.USD","LU1226288170.HKD","LU1328277881.USD","LU0140636845.USD","IE00B031HY20.USD","LU1226287792.SGD","LU1152091168.USD","LU0067412154.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1521","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0326950275.SGD","LU0880133367.SGD","LU1226287529.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU0501845795.SGD","LU1226288253.USD","LU0314109678.HKD","LU1813983027.USD","BK1515","LU1008478684.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","LU0315179316.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091754.HKD","LU1951186391.HKD","BK1191","IE0008368742.USD","HK0000165453.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.2065},{"period":"1month","weight":0.2033},{"period":"3month","weight":-0.0459},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.9027},{"period":"ytd","weight":0.9105}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.005459},{"month":2,"riseRate":0.741935,"avgChangeRate":0.096733},{"month":3,"riseRate":0.483871,"avgChangeRate":0.020489},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011493}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}